# FDA Inspection 1038960 - Hexal AG - December 21, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/hexal-ag/6cdd108a-abb7-4176-9fc4-dd6f56d8f544
Source feed: FDA_Inspections

> FDA Inspection 1038960 for Hexal AG on December 21, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1038960
- Company Name: Hexal AG
- Inspection Date: 2017-12-21
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 964809 - 2016-02-19](https://www.globalkeysolutions.net/records/fda_inspections/hexal-ag/282d1722-cb5b-43f6-b822-45e5edf0614b)
- [FDA Inspection 667152 - 2010-05-06](https://www.globalkeysolutions.net/records/fda_inspections/hexal-ag/48a1169d-e1f8-47f1-b9e0-3bcb102b8b16)

Company: https://www.globalkeysolutions.net/companies/hexal-ag/15c9b33f-4054-4bfc-9cc1-3dcf8c1bb7da

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c